Trends in Cardiovascular Medicine
Volume 15, Issue 5 , Pages 190-194 , July 2005

Hesr, a Mediator of the Notch Signaling, Functions in Heart and Vessel Development

References 

  1. Abdelwahid E, Pelliniemi LJ, Jokinen E. Cell death and differentiation in the development of the endocardial cushion of the embryonic heart. Microsc Res Tech. 2002;58:395–403
  2. Armstrong EJ, Bischoff J. Heart valve development: Endothelial cell signaling and differentiation. Circ Res. 2004;95:459–470
  3. De Lange FJ, Moorman AF, Anderson RH, et al. Lineage and morphogenetic analysis of the cardiac valves. Circ Res. 2004;95:645–654
  4. Donovan J, Kordylewska A, Jan Y, et al. Tetralogy of fallot and other congenital heart defects in hey2 mutant mice. Curr Biol. 2002;12:1605–1607
  5. Fischer A, Gessler M. Hey genes in cardiovascular development. Trends Cardiovasc Med. 2003;13:221–226
  6. Fischer A, Klamt B, Schumacher N, et al. Phenotypic variability in Hey2 −/− mice and absence of HEY2 mutations in patients with congenital heart defects or Alagille syndrome. Mamm Genome. 2004;15:711–716
  7. Fischer A, Schumacher N, Maier M, et al. The Notch target genes Hey1 and Hey2 are required for embryonic vascular development. Genes Dev. 2004;18:901–911
  8. Gessler M, Knobeloch K, Helisch A, et al. Mouse gridlock. No aortic coarctation or seficiency, but fatal cardiac defects in Hey2 −/− mice. Curr Biol. 2002;12:1601–1603
  9. Grego-Bessa J, Diez J, Timmerman L, et al. Notch and epithelial–mesenchyme transition in development and tumor progression: Another turn of the screw. Cell Cycle. 2004;3:718–721
  10. Gridley T. Notch signaling and inherited disease syndromes. Hum Mol Genet. 2003;12(Spec No 1):R9–R13
  11. Han Z, Bodmer R. Myogenic cells fates are antagonized by Notch only in asymmetric lineages of the Drosophila heart, with or without cell division. Development. 2003;130:3039–3051
  12. Iso T, Sartorelli V, Chung G, et al. HERP, a new primary target of Notch regulated by ligand binding. Mol Cell Biol. 2001;21:6071–6079
  13. Iso T, Kedes L, Hamamori Y. HES and HERP families: Multiple effectors of the Notch signaling pathway. J Cell Physiol. 2003;194:237–255
  14. Itoh F, Itoh S, Goumans MJ, et al. Synergy and antagonism between Notch and BMP receptor signaling pathways in endothelial cells. EMBO J. 2004;23:541–551
  15. Jones KL. Smith's recognizable patterns of human malformation. Philadelphia: Saunders; 1997;
  16. Kokubo H, Miyagawa-Tomita S, Tomimatsu H, et al. Targeted disruption of hesr2 results in atrioventricular valve anomalies that lead to heart dysfunction. Circ Res. 2004;95:540–547
  17. Kokubo H, Miyagawa-Tomita S, Nakazawa M, et al. Mouse hesr1 and hesr2 genes are redundantly required to mediate Notch signaling in the developing cardiovascular system. Dev Biol. 2005;278:301–309
  18. Krebs LT, Xue Y, Norton CR, et al. Notch signaling is essential for vascular morphogenesis in mice. Genes Dev. 2000;14:1343–1352
  19. Lai EC. Notch signaling: Control of cell communication and cell fate. Development. 2004;131:965–973
  20. Maier MM, Gessler M. Comparative analysis of the human and mouse Hey1 promoter: Hey genes are new Notch target genes. Biochem Biophys Res Commun. 2000;275:652–660
  21. Nakagawa O, McFadden DG, Nakagawa M, et al. Members of the HRT family of basic helix–loop–helix proteins act as transcriptional repressors downstream of Notch signaling. Proc Natl Acad Sci U S A. 2000;97:13655–13660
  22. Person AD, Klewer SE, Runyan RB. Cell biology of cardiac cushion development. Int Rev Cytol. 2005;243:287–335
  23. Rones MS, McLaughlin KA, Raffin M, et al. Serrate and Notch specify cell fates in the heart field by suppressing cardiomyogenesis. Development. 2000;127:3865–3876
  24. Sakata Y, Kamei CN, Nakagami H, et al. Ventricular septal defect and cardiomyopathy in mice lacking the transcription factor CHF1/Hey2. Proc Natl Acad Sci U S A. 2002;99:16197–16202
  25. Sakata Y, Xiang F, Chen Z, et al. Transcription factor CHF1/Hey2 regulates neointimal formation in vivo and vascular smooth muscle proliferation and migration in vitro. Arterioscler Thromb Vasc Biol. 2004;24:2069–2074
  26. Sarkozy A, Conti E, D'Agostino R, et al. ZFPM2/FOG2 and HEY2 genes analysis in nonsyndromic tricuspid atresia. Am J Med Genet A. 2005;133A:68–70
  27. Shawber CJ, Kitajewski J. Notch function in the vasculature: Insights from zebrafish, mouse and man. Bioessays. 2004;26:225–234
  28. Timmerman LA, Grego-Bessa J, Raya A, et al. Notch promotes epithelial–mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev. 2004;18:99–115
  29. Uyttendaele H, Closson V, Wu G, et al. Notch4 and Jagged-1 induce microvessel differentiation of rat brain endothelial cells. Microvasc Res. 2000;60:91–103
  30. Weinstein BM, Stemple DL, Driever W, et al. Gridlock, a localized heritable vascular patterning defect in the zebrafish. Nat Med. 1995;1:1143–1147
  31. Zavadil J, Cermak L, Soto-Nieves N, et al. Integration of TGF-beta/Smad and Jagged1/Notch signalling in epithelial-to-mesenchymal transition. EMBO J. 2004;23:1155–1165
  32. Zhong TP, Rosenberg M, Mohideen MA, et al. Gridlock, an HLH gene required for assembly of the aorta in zebrafish. Science. 2000;287:1820–1824
  33. Zhong TP, Childs S, Leu JP, et al. Gridlock signalling pathway fashions the first embryonic artery. Nature. 2001;414:216–220

PII: S1050-1738(05)00059-9

doi: 10.1016/j.tcm.2005.05.005

Trends in Cardiovascular Medicine
Volume 15, Issue 5 , Pages 190-194 , July 2005

Article Tools

* Image Usage & Resolution